HEADER TRANSFERASE/TRANSFERASE INHIBITOR 22-FEB-23 8GA2 TITLE BROMODOMAIN OF CBP LIGANDED WITH INHIBITOR ICBP5 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CREB-BINDING PROTEIN; COMPND 3 CHAIN: A, D, C, B; COMPND 4 FRAGMENT: BROMODOMAIN, RESIDUES 1082-1197; COMPND 5 SYNONYM: HISTONE LYSINE ACETYLTRANSFERASE CREBBP,PROTEIN-LYSINE COMPND 6 ACETYLTRANSFERASE CREBBP; COMPND 7 EC: 2.3.1.48,2.3.1.-; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CREBBP, CBP; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PNIC28-BSA4 KEYWDS BROMODOMAIN, COMPLEX, TRANSCRIPTION, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR E.SCHONBRUNN,M.BIKOWITZ REVDAT 2 08-MAY-24 8GA2 1 JRNL REVDAT 1 28-FEB-24 8GA2 0 JRNL AUTH N.A.M.SHENDY,M.BIKOWITZ,L.H.SIGUA,Y.ZHANG,A.MERCIER, JRNL AUTH 2 Y.KHASHANA,S.NANCE,Q.LIU,I.M.DELAHUNTY,S.ROBINSON,V.GOEL, JRNL AUTH 3 M.G.REES,M.A.RONAN,T.WANG,M.KOCAK,J.A.ROTH,Y.WANG, JRNL AUTH 4 B.B.FREEMAN,B.A.ORR,B.J.ABRAHAM,M.F.ROUSSEL,E.SCHONBRUNN, JRNL AUTH 5 J.QI,A.D.DURBIN JRNL TITL GROUP 3 MEDULLOBLASTOMA TRANSCRIPTIONAL NETWORKS COLLAPSE JRNL TITL 2 UNDER DOMAIN SPECIFIC EP300/CBP INHIBITION. JRNL REF NAT COMMUN V. 15 3483 2024 JRNL REFN ESSN 2041-1723 JRNL PMID 38664416 JRNL DOI 10.1038/S41467-024-47102-0 REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1-4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.05 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.400 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 41489 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.192 REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2075 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.0500 - 4.5600 1.00 2690 142 0.1676 0.1777 REMARK 3 2 4.5600 - 3.6200 1.00 2673 141 0.1488 0.1856 REMARK 3 3 3.6200 - 3.1600 1.00 2652 139 0.1905 0.2352 REMARK 3 4 3.1600 - 2.8700 1.00 2644 140 0.2101 0.2355 REMARK 3 5 2.8700 - 2.6700 1.00 2640 139 0.2190 0.2781 REMARK 3 6 2.6700 - 2.5100 1.00 2685 141 0.2097 0.2674 REMARK 3 7 2.5100 - 2.3900 1.00 2630 138 0.2057 0.2129 REMARK 3 8 2.3800 - 2.2800 1.00 2625 139 0.2080 0.2496 REMARK 3 9 2.2800 - 2.1900 0.99 2649 139 0.2024 0.2587 REMARK 3 10 2.1900 - 2.1200 1.00 2648 139 0.2111 0.2462 REMARK 3 11 2.1200 - 2.0500 0.99 2626 139 0.2130 0.2463 REMARK 3 12 2.0500 - 1.9900 1.00 2632 138 0.2106 0.2414 REMARK 3 13 1.9900 - 1.9400 0.99 2631 138 0.2283 0.2891 REMARK 3 14 1.9400 - 1.8900 0.98 2615 138 0.2470 0.2804 REMARK 3 15 1.8900 - 1.8500 0.91 2374 125 0.2504 0.3347 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.200 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.580 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 36.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 NULL REMARK 3 ANGLE : 1.159 NULL REMARK 3 CHIRALITY : 0.063 580 REMARK 3 PLANARITY : 0.008 722 REMARK 3 DIHEDRAL : 9.003 538 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 0.7949 6.2134 17.8269 REMARK 3 T TENSOR REMARK 3 T11: 0.1944 T22: 0.1940 REMARK 3 T33: 0.1861 T12: 0.0034 REMARK 3 T13: -0.0080 T23: 0.0109 REMARK 3 L TENSOR REMARK 3 L11: 0.1760 L22: 0.3044 REMARK 3 L33: 0.2343 L12: -0.0069 REMARK 3 L13: -0.0246 L23: 0.0034 REMARK 3 S TENSOR REMARK 3 S11: 0.0205 S12: -0.0221 S13: -0.0281 REMARK 3 S21: 0.0283 S22: -0.0057 S23: -0.0044 REMARK 3 S31: -0.0259 S32: -0.0140 S33: -0.0181 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8GA2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-FEB-23. REMARK 100 THE DEPOSITION ID IS D_1000272446. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-DEC-21 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0332 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS JAN 10, 2022 REMARK 200 DATA SCALING SOFTWARE : XSCALE JAN 10, 2022 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41493 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 46.050 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.9 REMARK 200 DATA REDUNDANCY IN SHELL : 5.20 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX 1.20.1-4487 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.57 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.26 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M MAGNESIUM CHLORIDE HEXAHYDRATE; REMARK 280 0.1 M TRIS HYDROCHLORIDE PH 8.5; 30% W/V POLYETHYLENE GLYCOL 4, REMARK 280 000, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 53.50500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS C 1082 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A1082 CG CD CE NZ REMARK 470 LYS D1082 CG CD CE NZ REMARK 470 GLU C1088 CG CD OE1 OE2 REMARK 470 LYS B1082 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH D 1345 O HOH D 1351 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE D1122 76.03 -118.28 REMARK 500 ILE C1084 -1.01 -59.67 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH D1356 DISTANCE = 5.93 ANGSTROMS DBREF 8GA2 A 1082 1197 UNP Q92793 CBP_HUMAN 1082 1197 DBREF 8GA2 D 1082 1197 UNP Q92793 CBP_HUMAN 1082 1197 DBREF 8GA2 C 1082 1197 UNP Q92793 CBP_HUMAN 1082 1197 DBREF 8GA2 B 1082 1197 UNP Q92793 CBP_HUMAN 1082 1197 SEQRES 1 A 116 LYS LYS ILE PHE LYS PRO GLU GLU LEU ARG GLN ALA LEU SEQRES 2 A 116 MET PRO THR LEU GLU ALA LEU TYR ARG GLN ASP PRO GLU SEQRES 3 A 116 SER LEU PRO PHE ARG GLN PRO VAL ASP PRO GLN LEU LEU SEQRES 4 A 116 GLY ILE PRO ASP TYR PHE ASP ILE VAL LYS ASN PRO MET SEQRES 5 A 116 ASP LEU SER THR ILE LYS ARG LYS LEU ASP THR GLY GLN SEQRES 6 A 116 TYR GLN GLU PRO TRP GLN TYR VAL ASP ASP VAL TRP LEU SEQRES 7 A 116 MET PHE ASN ASN ALA TRP LEU TYR ASN ARG LYS THR SER SEQRES 8 A 116 ARG VAL TYR LYS PHE CYS SER LYS LEU ALA GLU VAL PHE SEQRES 9 A 116 GLU GLN GLU ILE ASP PRO VAL MET GLN SER LEU GLY SEQRES 1 D 116 LYS LYS ILE PHE LYS PRO GLU GLU LEU ARG GLN ALA LEU SEQRES 2 D 116 MET PRO THR LEU GLU ALA LEU TYR ARG GLN ASP PRO GLU SEQRES 3 D 116 SER LEU PRO PHE ARG GLN PRO VAL ASP PRO GLN LEU LEU SEQRES 4 D 116 GLY ILE PRO ASP TYR PHE ASP ILE VAL LYS ASN PRO MET SEQRES 5 D 116 ASP LEU SER THR ILE LYS ARG LYS LEU ASP THR GLY GLN SEQRES 6 D 116 TYR GLN GLU PRO TRP GLN TYR VAL ASP ASP VAL TRP LEU SEQRES 7 D 116 MET PHE ASN ASN ALA TRP LEU TYR ASN ARG LYS THR SER SEQRES 8 D 116 ARG VAL TYR LYS PHE CYS SER LYS LEU ALA GLU VAL PHE SEQRES 9 D 116 GLU GLN GLU ILE ASP PRO VAL MET GLN SER LEU GLY SEQRES 1 C 116 LYS LYS ILE PHE LYS PRO GLU GLU LEU ARG GLN ALA LEU SEQRES 2 C 116 MET PRO THR LEU GLU ALA LEU TYR ARG GLN ASP PRO GLU SEQRES 3 C 116 SER LEU PRO PHE ARG GLN PRO VAL ASP PRO GLN LEU LEU SEQRES 4 C 116 GLY ILE PRO ASP TYR PHE ASP ILE VAL LYS ASN PRO MET SEQRES 5 C 116 ASP LEU SER THR ILE LYS ARG LYS LEU ASP THR GLY GLN SEQRES 6 C 116 TYR GLN GLU PRO TRP GLN TYR VAL ASP ASP VAL TRP LEU SEQRES 7 C 116 MET PHE ASN ASN ALA TRP LEU TYR ASN ARG LYS THR SER SEQRES 8 C 116 ARG VAL TYR LYS PHE CYS SER LYS LEU ALA GLU VAL PHE SEQRES 9 C 116 GLU GLN GLU ILE ASP PRO VAL MET GLN SER LEU GLY SEQRES 1 B 116 LYS LYS ILE PHE LYS PRO GLU GLU LEU ARG GLN ALA LEU SEQRES 2 B 116 MET PRO THR LEU GLU ALA LEU TYR ARG GLN ASP PRO GLU SEQRES 3 B 116 SER LEU PRO PHE ARG GLN PRO VAL ASP PRO GLN LEU LEU SEQRES 4 B 116 GLY ILE PRO ASP TYR PHE ASP ILE VAL LYS ASN PRO MET SEQRES 5 B 116 ASP LEU SER THR ILE LYS ARG LYS LEU ASP THR GLY GLN SEQRES 6 B 116 TYR GLN GLU PRO TRP GLN TYR VAL ASP ASP VAL TRP LEU SEQRES 7 B 116 MET PHE ASN ASN ALA TRP LEU TYR ASN ARG LYS THR SER SEQRES 8 B 116 ARG VAL TYR LYS PHE CYS SER LYS LEU ALA GLU VAL PHE SEQRES 9 B 116 GLU GLN GLU ILE ASP PRO VAL MET GLN SER LEU GLY HET EDO A1201 4 HET YVK A1202 37 HET YVK D1201 37 HET YVK C1201 37 HET YVK B1201 37 HETNAM EDO 1,2-ETHANEDIOL HETNAM YVK (6S)-6-{(5M)-5-(3,5-DIMETHYL-1,2-OXAZOL-4-YL)-1-[(1S, HETNAM 2 YVK 4R)-4-METHOXYCYCLOHEXYL]-1H-BENZIMIDAZOL-2-YL}-1- HETNAM 3 YVK PHENYLPIPERIDIN-2-ONE HETSYN EDO ETHYLENE GLYCOL FORMUL 5 EDO C2 H6 O2 FORMUL 6 YVK 4(C30 H34 N4 O3) FORMUL 10 HOH *190(H2 O) HELIX 1 AA1 LYS A 1086 ARG A 1103 1 18 HELIX 2 AA2 SER A 1108 ARG A 1112 5 5 HELIX 3 AA3 ASP A 1124 VAL A 1129 1 6 HELIX 4 AA4 ASP A 1134 THR A 1144 1 11 HELIX 5 AA5 GLU A 1149 ASN A 1168 1 20 HELIX 6 AA6 SER A 1172 LEU A 1196 1 25 HELIX 7 AA7 LYS D 1086 ARG D 1103 1 18 HELIX 8 AA8 SER D 1108 ARG D 1112 5 5 HELIX 9 AA9 ASP D 1116 GLY D 1121 1 6 HELIX 10 AB1 ASP D 1124 VAL D 1129 1 6 HELIX 11 AB2 ASP D 1134 GLY D 1145 1 12 HELIX 12 AB3 GLU D 1149 ASN D 1168 1 20 HELIX 13 AB4 SER D 1172 GLY D 1197 1 26 HELIX 14 AB5 LYS C 1086 ARG C 1103 1 18 HELIX 15 AB6 SER C 1108 ARG C 1112 5 5 HELIX 16 AB7 ASP C 1116 GLY C 1121 1 6 HELIX 17 AB8 ASP C 1124 VAL C 1129 1 6 HELIX 18 AB9 ASP C 1134 THR C 1144 1 11 HELIX 19 AC1 GLU C 1149 ASN C 1168 1 20 HELIX 20 AC2 SER C 1172 GLY C 1197 1 26 HELIX 21 AC3 LYS B 1086 GLN B 1104 1 19 HELIX 22 AC4 SER B 1108 ARG B 1112 5 5 HELIX 23 AC5 ASP B 1116 GLY B 1121 1 6 HELIX 24 AC6 ASP B 1124 VAL B 1129 1 6 HELIX 25 AC7 ASP B 1134 GLY B 1145 1 12 HELIX 26 AC8 GLU B 1149 ASN B 1168 1 20 HELIX 27 AC9 SER B 1172 SER B 1195 1 24 CISPEP 1 ASP A 1105 PRO A 1106 0 9.08 CISPEP 2 ASP D 1105 PRO D 1106 0 10.00 CISPEP 3 ASP C 1105 PRO C 1106 0 8.57 CISPEP 4 ASP B 1105 PRO B 1106 0 3.70 CRYST1 45.860 107.010 55.830 90.00 113.98 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021805 0.000000 0.009699 0.00000 SCALE2 0.000000 0.009345 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019604 0.00000